WO1997015288A3 - Zubereitungen und verfahren zur stabilisierung biologischer materialien mittels trocknungsverfahren ohne einfrieren - Google Patents

Zubereitungen und verfahren zur stabilisierung biologischer materialien mittels trocknungsverfahren ohne einfrieren Download PDF

Info

Publication number
WO1997015288A3
WO1997015288A3 PCT/EP1996/004627 EP9604627W WO9715288A3 WO 1997015288 A3 WO1997015288 A3 WO 1997015288A3 EP 9604627 W EP9604627 W EP 9604627W WO 9715288 A3 WO9715288 A3 WO 9715288A3
Authority
WO
WIPO (PCT)
Prior art keywords
freezing
preparations
biological materials
substance mixtures
drying methods
Prior art date
Application number
PCT/EP1996/004627
Other languages
English (en)
French (fr)
Other versions
WO1997015288A2 (de
Inventor
Markus Mattern
Gerhard Winter
Original Assignee
Boehringer Mannheim Gmbh
Markus Mattern
Gerhard Winter
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7775640&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO1997015288(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority to DK96934811T priority Critical patent/DK0857060T3/da
Priority to AU72984/96A priority patent/AU712489B2/en
Priority to BR9611265A priority patent/BR9611265A/pt
Priority to KR10-1998-0703022A priority patent/KR100466670B1/ko
Priority to DE59608684T priority patent/DE59608684D1/de
Priority to JP9516286A priority patent/JPH11513700A/ja
Priority to NZ320276A priority patent/NZ320276A/xx
Priority to AT96934811T priority patent/ATE212541T1/de
Priority to PL96326358A priority patent/PL190657B1/pl
Application filed by Boehringer Mannheim Gmbh, Markus Mattern, Gerhard Winter filed Critical Boehringer Mannheim Gmbh
Priority to SI9630426T priority patent/SI0857060T1/xx
Priority to US09/051,918 priority patent/US7172999B2/en
Priority to HU9901314A priority patent/HU222601B1/hu
Priority to CA002235243A priority patent/CA2235243C/en
Priority to SK509-98A priority patent/SK283664B6/sk
Priority to IL12420496A priority patent/IL124204A/en
Priority to EP96934811A priority patent/EP0857060B1/de
Publication of WO1997015288A2 publication Critical patent/WO1997015288A2/de
Publication of WO1997015288A3 publication Critical patent/WO1997015288A3/de
Priority to NO19981868A priority patent/NO324728B1/no
Priority to US11/449,781 priority patent/US20070020289A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/443—Oxidoreductases (1) acting on CH-OH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F26—DRYING
    • F26B—DRYING SOLID MATERIALS OR OBJECTS BY REMOVING LIQUID THEREFROM
    • F26B5/00—Drying solid materials or objects by processes not involving the application of heat
    • F26B5/04—Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Mechanical Engineering (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Drying Of Solid Materials (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Storage Of Fruits Or Vegetables (AREA)

Abstract

Die vorliegende Erfindung betrifft Verfahren zur Herstellung von trockenen, teilamorphen, biologisches, insbesondere therapeutisch aktives Material enthaltenden Produkten, die makroskopisch homogene Substanzgemische darstellen, wobei die Substanzgemische ausgewählt sind aus je mindestens einer Substanz der Gruppe (i) Kohlenhydrat oder Zwitterion mit polarem Rest und deren Derivate, und (ii) Zwitterion mit apolarem Rest und dessen Derivate, dadurch gekennzeichnet, daß eine Lösung des biologischen oder therapeutisch aktiven Materials und der Substanzen (i) und (ii) hergestellt wird und die Lösung bei einer Produkttemperatur oberhalb des Gefrierpunktes der Lösung getrocknet wird. Ferner betrifft die Erfindung neue Substanzgemische, die durch das genannte Verfahren erhalten werden, sowie deren Verwendung in diagnostischen oder therapeutischen Verfahren.
PCT/EP1996/004627 1995-10-25 1996-10-24 Zubereitungen und verfahren zur stabilisierung biologischer materialien mittels trocknungsverfahren ohne einfrieren WO1997015288A2 (de)

Priority Applications (18)

Application Number Priority Date Filing Date Title
EP96934811A EP0857060B1 (de) 1995-10-25 1996-10-24 Zubereitungen und verfahren zur stabilisierung biologischer materialien mittels trocknungsverfahren ohne einfrieren
US09/051,918 US7172999B2 (en) 1995-10-25 1996-10-24 Method and preparations for stabilizing biological materials by drying methods without freezing
SI9630426T SI0857060T1 (en) 1995-10-25 1996-10-24 Method and preparations for stabilizing biological materials by drying methods without freezing
HU9901314A HU222601B1 (hu) 1995-10-25 1996-10-24 Készítmények és eljárás biológiai anyagok stabilizálására fagyasztás nélküli szárítással
AU72984/96A AU712489B2 (en) 1995-10-25 1996-10-24 Method and preparations for stabilizing biological materials by drying methods without freezing
JP9516286A JPH11513700A (ja) 1995-10-25 1996-10-24 凍結しない乾燥過程により生物材料を安定化するための調製物及び方法
NZ320276A NZ320276A (en) 1995-10-25 1996-10-24 Method and preparations for stabilizing biological materials by drying methods without freezing
AT96934811T ATE212541T1 (de) 1995-10-25 1996-10-24 Zubereitungen und verfahren zur stabilisierung biologischer materialien mittels trocknungsverfahren ohne einfrieren
PL96326358A PL190657B1 (pl) 1995-10-25 1996-10-24 Sposób wytwarzania suchych, częściowo amorficznych produktów, mieszanina substancji i zastosowanie kombinacji substancji
DK96934811T DK0857060T3 (da) 1995-10-25 1996-10-24 Præparater og fremgangsmåder til stabilisering af biologiske materialer ved hjælp af tørringsprocesser uden nedfrysning
BR9611265A BR9611265A (pt) 1995-10-25 1996-10-24 Preparações e processos para estabilização de materiais biológicos por meio de processos de secagem sem congelamento
DE59608684T DE59608684D1 (de) 1995-10-25 1996-10-24 Zubereitungen und verfahren zur stabilisierung biologischer materialien mittels trocknungsverfahren ohne einfrieren
KR10-1998-0703022A KR100466670B1 (ko) 1995-10-25 1996-10-24 비동결건조법에의한생물질의안정화제제및안정화방법
CA002235243A CA2235243C (en) 1995-10-25 1996-10-24 Method and preparations for stabilizing biological materials by drying methods without freezing
SK509-98A SK283664B6 (sk) 1995-10-25 1996-10-24 Spôsob prípravy suchých, čiastočne amorfných produktov, zmesi substancií získané týmto spôsobom, ich použitie a diagnostické prostriedky a terapeutické prípravky obsahujúce tieto zmesi
IL12420496A IL124204A (en) 1995-10-25 1996-10-24 A process for creating dry, partly amorphous materials, without freezing
NO19981868A NO324728B1 (no) 1995-10-25 1998-04-24 Fremgangsmate for fremstilling av torre, delvis amorfe produkter, stoffblanding, diagnostisk middel og preparat som omfatter stofflandingen, anvendelse av stoffblandingen til fremstilling av diagnostika og terapeutiske midler og fremgangsmate for stabilisering av biologisk eller terapeutisk aktive materialer
US11/449,781 US20070020289A1 (en) 1995-10-25 2006-06-09 Preparations and processes for stabilizing biological materials by means of drying processes without freezing

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19539574A DE19539574A1 (de) 1995-10-25 1995-10-25 Zubereitungen und Verfahren zur Stabilisierung biologischer Materialien mittels Trocknungsverfahren ohne Einfrieren
DE19539574.3 1995-10-25

Related Child Applications (3)

Application Number Title Priority Date Filing Date
US09/051,918 A-371-Of-International US7172999B2 (en) 1995-10-25 1996-10-24 Method and preparations for stabilizing biological materials by drying methods without freezing
US10/141,960 Division US20030059468A1 (en) 1995-10-25 2002-05-10 Preparations and processes for stabilizing biological materials by means of drying processes without freezing
US11/449,781 Continuation US20070020289A1 (en) 1995-10-25 2006-06-09 Preparations and processes for stabilizing biological materials by means of drying processes without freezing

Publications (2)

Publication Number Publication Date
WO1997015288A2 WO1997015288A2 (de) 1997-05-01
WO1997015288A3 true WO1997015288A3 (de) 1997-05-29

Family

ID=7775640

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1996/004627 WO1997015288A2 (de) 1995-10-25 1996-10-24 Zubereitungen und verfahren zur stabilisierung biologischer materialien mittels trocknungsverfahren ohne einfrieren

Country Status (25)

Country Link
US (3) US7172999B2 (de)
EP (1) EP0857060B1 (de)
JP (2) JPH11513700A (de)
KR (1) KR100466670B1 (de)
CN (1) CN1130196C (de)
AT (1) ATE212541T1 (de)
AU (1) AU712489B2 (de)
BR (1) BR9611265A (de)
CA (1) CA2235243C (de)
CZ (1) CZ293456B6 (de)
DE (2) DE19539574A1 (de)
DK (1) DK0857060T3 (de)
ES (1) ES2170274T3 (de)
HU (1) HU222601B1 (de)
IL (1) IL124204A (de)
MX (1) MX9803264A (de)
NO (1) NO324728B1 (de)
NZ (1) NZ320276A (de)
PL (1) PL190657B1 (de)
PT (1) PT857060E (de)
RU (1) RU2191003C2 (de)
SK (1) SK283664B6 (de)
TR (1) TR199800715T2 (de)
WO (1) WO1997015288A2 (de)
ZA (1) ZA968930B (de)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6582728B1 (en) 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
DE19539574A1 (de) * 1995-10-25 1997-04-30 Boehringer Mannheim Gmbh Zubereitungen und Verfahren zur Stabilisierung biologischer Materialien mittels Trocknungsverfahren ohne Einfrieren
EP0852951A1 (de) * 1996-11-19 1998-07-15 Roche Diagnostics GmbH Stabile lyophilisierte pharmazeutische Zubereitungen von mono- oder polyklonalen Antikörpern
EP0913177A1 (de) * 1997-11-03 1999-05-06 Roche Diagnostics GmbH Verfahren zur Herstellung trockener, amorpher Produkte enthaltend biologisch aktive Materialien mittels Konvektionstrocknung, insbesondere Sprühtrocknung
EP0913178A1 (de) * 1997-11-03 1999-05-06 Boehringer Mannheim Gmbh Verfahren zur Herstellung trockener, amorpher Produkte enthaltend biologisch aktive Materialen mittels Konvektionstrocknung und die erhaltenen Produkte
BR9905867A (pt) * 1998-11-06 2001-01-23 Bio Sidus S A Linhagem celular produtora de eritropoietina humana recombinante e a eritropoietina humana recombinante produzida por esta célula
PL203797B1 (pl) * 1999-04-09 2009-11-30 Ortho Mcneil Pharm Inc Kompozycje farmaceutyczne erytropoetyny
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
EP1290390A1 (de) * 2000-06-07 2003-03-12 Universal Preservation Technologies, Inc. Barrieretechnologie in industriellem umfang für konservierung von empfindlichen biologischen materialien
GB0017999D0 (en) * 2000-07-21 2000-09-13 Smithkline Beecham Biolog Novel device
EP1854454B1 (de) * 2002-01-16 2013-11-06 Boehringer Ingelheim Pharma GmbH & Co. KG Verfahren zur Herstellung von amorphen Telmisartan
KR100556503B1 (ko) * 2002-11-26 2006-03-03 엘지전자 주식회사 건조기의 건조 시간제어 방법
US8377952B2 (en) * 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
JP4896006B2 (ja) 2004-04-08 2012-03-14 バイオマトリカ， インコーポレイテッド ライフサイエンスのためのサンプル保存とサンプル管理との統合
US20080176209A1 (en) * 2004-04-08 2008-07-24 Biomatrica, Inc. Integration of sample storage and sample management for life science
US20060099567A1 (en) * 2004-04-08 2006-05-11 Biomatrica, Inc. Integration of sample storage and sample management for life science
GB0517688D0 (en) * 2005-08-31 2005-10-05 Cambridge Biostability Ltd Improvements in the stabilisation of biological materials
GB2430880A (en) * 2005-10-04 2007-04-11 Cambridge Biostability Ltd Pharmaceutical compositions stabilized in glassy particles
GB0523638D0 (en) * 2005-11-21 2005-12-28 Cambridge Biostability Ltd Pharmaceutical device for the administration of substances to patients
US8968721B2 (en) 2005-12-28 2015-03-03 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
JP5214464B2 (ja) 2005-12-28 2013-06-19 アドバンスド バイオニュートリション コーポレーション 多糖類、糖類およびポリオール類の乾燥マトリックスを含む、ガラス形態の、プロバイオティクス細菌用送達媒体およびその製造方法
CA2673120C (en) 2006-12-18 2012-08-07 Advanced Bionutrition Corporation A dry food product containing live probiotic
US8466187B2 (en) * 2007-09-18 2013-06-18 Thermolife International, Llc Amino acid compositions
EP2410996B1 (de) 2009-03-27 2017-08-02 Advanced Bionutrition Corp. Impfstoffe in mikropartikelform zur oralen oder nasalen impfung und stärkung von tieren einschliesslich fischen
EP2236520A1 (de) * 2009-03-31 2010-10-06 Leukocare Ag Stabilisierungszusammensetzung für immobilisierte Biomoleküle
CN102459568A (zh) * 2009-05-26 2012-05-16 先进生物营养公司 包含生物活性微生物和/或生物活性材料的稳定干粉组合物及其制造方法
TWI505838B (zh) 2010-01-20 2015-11-01 Chugai Pharmaceutical Co Ltd Stabilized antibody solution containing
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
PL2529004T3 (pl) 2010-01-28 2017-12-29 Advanced Bionutrition Corporation Sucha szklista kompozycja zawierająca bioaktywny materiał
US9845489B2 (en) 2010-07-26 2017-12-19 Biomatrica, Inc. Compositions for stabilizing DNA, RNA and proteins in saliva and other biological samples during shipping and storage at ambient temperatures
WO2012018638A2 (en) 2010-07-26 2012-02-09 Biomatrica, Inc. Compositions for stabilizing dna, rna and proteins in blood and other biological samples during shipping and storage at ambient temperatures
AU2011289272B2 (en) 2010-08-13 2015-02-05 Advanced Bionutrition Corporation Dry storage stabilizing composition for biological materials
CN102408467B (zh) * 2010-09-26 2014-03-05 海口维瑅瑷生物研究院 真空干燥蛋白的方法、制得的蛋白产品和试剂盒
WO2012142474A2 (en) 2011-04-13 2012-10-18 Thermolife International, Llc N-acetyl beta alanine methods of use
WO2014100755A2 (en) 2012-12-20 2014-06-26 Biomatrica, Inc. Formulations and methods for stabilizing pcr reagents
ES2786373T3 (es) 2014-06-10 2020-10-09 Biomatrica Inc Estabilización de trombocitos a temperaturas ambiente
US9868944B2 (en) * 2014-12-19 2018-01-16 Roche Molecular Systems, Inc. Reaction mixtures
KR102567744B1 (ko) * 2015-02-11 2023-08-18 에바 뉴트리션 인크 생존 가능한 대장균을 삽입하기 위한 향상된 건조 기질, 이의 제조 방법 및 용도
EP4039253A1 (de) 2015-04-29 2022-08-10 Radius Pharmaceuticals, Inc. Verfahren zur behandlung von krebs
AU2016297986B8 (en) 2015-07-29 2020-06-11 Advanced Bionutrition Corp. Stable dry probiotic compositions for special dietary uses
ES2946184T3 (es) 2015-12-08 2023-07-13 Biomatrica Inc Reducción de la velocidad de eritrosedimentación
CN106831466B (zh) * 2016-12-28 2018-05-22 安徽省虹升生物股份有限公司 一种β-丙氨酸的常规储存方法
EP3565542B1 (de) 2017-01-05 2024-04-10 Radius Pharmaceuticals, Inc. Polymorphe formen von rad1901-2hcl
BR112020021134A2 (pt) * 2018-04-16 2021-03-23 Merck Patent Gmbh aditivos para formulações de proteínas para aprimorar estabilidade térmica
JP7473486B2 (ja) 2018-07-04 2024-04-23 ラジウス ファーマシューティカルズ，インコーポレイテッド Ｒａｄ１９０１－２ｈｃｌの多形形態
KR20230038752A (ko) * 2020-07-13 2023-03-21 메르크 파텐트 게엠베하 고농축 단백질 제형을 위한 점도 감소 부형제 및 이들의 조합
US11865139B2 (en) 2020-11-12 2024-01-09 Thermolife International, Llc Method of treating migraines and headaches
CN114480129A (zh) * 2022-01-13 2022-05-13 力因精准医疗产品（上海）有限公司 一种人粪便保存液及使用方法

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0306824A2 (de) * 1987-09-05 1989-03-15 Roche Diagnostics GmbH Stabilisierte Humanprotein-Präparate
EP0325112A1 (de) * 1988-01-18 1989-07-26 Hoechst Aktiengesellschaft Stabilisierung von Cephalosporinderivaten durch Trocknung mit einem Stabilisator sowie stabile Zubereitungsformen mit Cephalosporinderivaten
WO1990012029A1 (en) * 1989-04-11 1990-10-18 Immunobiology Research Institute, Inc. Lyophilized peptide formulations
EP0444692A1 (de) * 1990-03-01 1991-09-04 Mochida Pharmaceutical Co., Ltd. Thrombin-Zusammensetzung zur oralen Verabreichung
EP0547422A2 (de) * 1991-12-14 1993-06-23 BASF Aktiengesellschaft Stabile pulverförmige Vitamin- und/oder Carotinoid-Präparate und Verfahren zu deren Herstellung
DE4242863A1 (de) * 1992-12-18 1994-06-23 Boehringer Mannheim Gmbh Stabile lyophilisierte pharmazeutische Zubereitungen von G-CSF

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3714353A (en) * 1959-08-11 1973-01-30 Upjohn Co THERAPEUTIC COMPOSITIONS COMPRISING A 6 alpha ; 9 alpha -DIFLUORO-11 beta ,17 alpha ,21-TRIHYDROXY-16 alpha -METHYL-1,4-PREGNADIENE-3,20-DIONE AND 21-ACYLATES
US3852461A (en) * 1971-08-04 1974-12-03 Upjohn Co Benzodiapines used as minor tranquilizers
JPS5836954B2 (ja) * 1980-03-31 1983-08-12 栄研化学株式会社 酵素の安定化剤
JPS5967228A (ja) 1982-10-07 1984-04-16 Green Cross Corp:The 寒冷不溶性グロブリンの凍結乾燥方法
JPS6197229A (ja) * 1984-10-18 1986-05-15 Chugai Pharmaceut Co Ltd 安定なエリトロポエチン製剤
US4732889A (en) * 1985-02-06 1988-03-22 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical composition for the treatment of the anemia of rheumatoid arthritis
US4788072A (en) * 1985-08-15 1988-11-29 Toshimitsu Kawamura Method of dehydrating foods
US4808617A (en) 1985-12-18 1989-02-28 Bristol-Myers Company Lyophilized or precipitated cephalosporin zwitterion and salt combination
US5051406A (en) * 1987-03-04 1991-09-24 Nippon Hypox Laboratories Incorporated Pharmaceutical composition using albumin as a carrier and process for producing the same
US4886742A (en) * 1987-06-15 1989-12-12 Coulter Corporation Enzyme immunoassay for detecting HIV antigens in human sera
JPH0761955B2 (ja) 1988-04-28 1995-07-05 国立予防衛生研究所長 凍結乾燥ａ型肝炎ワクチン
US5202117A (en) 1988-08-24 1993-04-13 Koichiro Tsuji Method of treating thrombi with g-csf
JPH0296536A (ja) 1988-09-29 1990-04-09 Green Cross Corp:The プラスミノゲン乾燥製剤
JP2739584B2 (ja) 1989-01-06 1998-04-15 株式会社ミドリ十字 ウロキナーゼ型プラスミノーゲンアクチベーター乾燥製剤
US5186944A (en) * 1989-02-15 1993-02-16 Eimei Company Ltd. Therapeutic medicament for thrombosis
JPH0775519B2 (ja) 1989-10-06 1995-08-16 東洋製罐株式会社 ドライパック包装食品の製造方法
GB9001987D0 (en) * 1990-01-29 1990-03-28 Janssen Pharmaceutica Nv Improved cyclodextrin based erythropietin formulation
US5200399A (en) * 1990-09-14 1993-04-06 Boyce Thompson Institute For Plant Research, Inc. Method of protecting biological materials from destructive reactions in the dry state
US5217741A (en) 1991-01-25 1993-06-08 Snow Brand Milk Products Co., Ltd. Solution containing whey protein, whey protein gel, whey protein powder and processed food product produced by using the same
AU659645B2 (en) * 1991-06-26 1995-05-25 Inhale Therapeutic Systems Storage of materials
JP2818834B2 (ja) * 1991-08-12 1998-10-30 大塚製薬株式会社 ＩＬ−１α安定化医薬製剤
SE9201073D0 (sv) 1992-04-03 1992-04-03 Kabi Pharmacia Ab Protein formulation
IL105553A (en) 1992-05-06 1998-01-04 Janssen Pharmaceutica Inc Solid dosage forms consisting of a porous network of matrix that releases a substance that dissipates rapidly in water
IT1254359B (it) 1992-05-11 1995-09-14 Serono Cesare Ist Ricerca Composizioni farmaceutiche contenenti il-6
US6582728B1 (en) 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
JP3168550B2 (ja) * 1992-12-02 2001-05-21 株式会社林原生物化学研究所 脱水剤およびそれを用いる含水物の脱水方法並びにその方法で得られる脱水物品
US5354934A (en) * 1993-02-04 1994-10-11 Amgen Inc. Pulmonary administration of erythropoietin
MX9603936A (es) 1994-03-07 1997-05-31 Inhale Therapeutic Syst Metodos y composiciones para el suministro pulmonar de insulina.
US5955448A (en) * 1994-08-19 1999-09-21 Quadrant Holdings Cambridge Limited Method for stabilization of biological substances during drying and subsequent storage and compositions thereof
FR2719479B1 (fr) * 1994-05-04 1996-07-26 Sanofi Elf Formulation stable lyophilisée comprenant une protéine: kit de dosage.
AU696387B2 (en) 1994-05-18 1998-09-10 Inhale Therapeutic Systems, Inc. Methods and compositions for the dry powder formulation of interferons
IL116085A (en) 1994-12-16 1999-12-31 Ortho Pharma Corp Spray dried erythropoietin
WO1996032096A1 (en) 1995-04-14 1996-10-17 Inhale Therapeutic Systems Powdered pharmaceutical formulations having improved dispersibility
US5728678A (en) 1995-06-06 1998-03-17 Nestec Ltd. Method and composition for providing nutrition to a renal failure patient
DE19538687A1 (de) 1995-10-17 1997-04-24 Boehringer Mannheim Gmbh Stabile pharmazeutische Darreichungsformen enthaltend Parathormon
DE19539574A1 (de) * 1995-10-25 1997-04-30 Boehringer Mannheim Gmbh Zubereitungen und Verfahren zur Stabilisierung biologischer Materialien mittels Trocknungsverfahren ohne Einfrieren

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0306824A2 (de) * 1987-09-05 1989-03-15 Roche Diagnostics GmbH Stabilisierte Humanprotein-Präparate
EP0325112A1 (de) * 1988-01-18 1989-07-26 Hoechst Aktiengesellschaft Stabilisierung von Cephalosporinderivaten durch Trocknung mit einem Stabilisator sowie stabile Zubereitungsformen mit Cephalosporinderivaten
WO1990012029A1 (en) * 1989-04-11 1990-10-18 Immunobiology Research Institute, Inc. Lyophilized peptide formulations
EP0444692A1 (de) * 1990-03-01 1991-09-04 Mochida Pharmaceutical Co., Ltd. Thrombin-Zusammensetzung zur oralen Verabreichung
EP0547422A2 (de) * 1991-12-14 1993-06-23 BASF Aktiengesellschaft Stabile pulverförmige Vitamin- und/oder Carotinoid-Präparate und Verfahren zu deren Herstellung
DE4242863A1 (de) * 1992-12-18 1994-06-23 Boehringer Mannheim Gmbh Stabile lyophilisierte pharmazeutische Zubereitungen von G-CSF

Also Published As

Publication number Publication date
DE59608684D1 (de) 2002-03-14
US20070020289A1 (en) 2007-01-25
NO981868D0 (no) 1998-04-24
HUP9901314A2 (hu) 1999-07-28
JPH11513700A (ja) 1999-11-24
IL124204A (en) 2001-10-31
US20010055617A1 (en) 2001-12-27
AU7298496A (en) 1997-05-15
ZA968930B (en) 1998-04-24
NO324728B1 (no) 2007-12-03
ATE212541T1 (de) 2002-02-15
HUP9901314A3 (en) 2000-02-28
SK50998A3 (en) 1998-12-02
EP0857060A2 (de) 1998-08-12
KR100466670B1 (ko) 2005-09-07
TR199800715T2 (xx) 1998-08-21
NO981868L (no) 1998-06-25
HU222601B1 (hu) 2003-08-28
PT857060E (pt) 2002-07-31
KR19990067082A (ko) 1999-08-16
PL190657B1 (pl) 2005-12-30
EP0857060B1 (de) 2002-01-30
SK283664B6 (sk) 2003-11-04
MX9803264A (es) 1998-09-30
CA2235243A1 (en) 1997-05-01
AU712489B2 (en) 1999-11-11
RU2191003C2 (ru) 2002-10-20
DK0857060T3 (da) 2002-05-13
CN1205628A (zh) 1999-01-20
CA2235243C (en) 2003-04-22
JP2007236975A (ja) 2007-09-20
US7172999B2 (en) 2007-02-06
WO1997015288A2 (de) 1997-05-01
DE19539574A1 (de) 1997-04-30
CN1130196C (zh) 2003-12-10
US20030059468A1 (en) 2003-03-27
CZ117998A3 (cs) 1998-11-11
CZ293456B6 (cs) 2004-05-12
PL326358A1 (en) 1998-09-14
ES2170274T3 (es) 2002-08-01
NZ320276A (en) 1999-11-29
BR9611265A (pt) 1999-05-04

Similar Documents

Publication Publication Date Title
WO1997015288A3 (de) Zubereitungen und verfahren zur stabilisierung biologischer materialien mittels trocknungsverfahren ohne einfrieren
AU6766890A (en) Treating fruit materials
HUT51865A (en) Herbicides containing as active substance derivatives of salycil acid or their sulfhur-analoges, further compositions regulating the growt of plants containing salycil acid derivatives and process for production of the active substances
DE3787445D1 (de) Verfahren zur Isolierung von langkettiger Nukleinsäure.
HUT51861A (en) Fungicides containing as active substance derivatives of amid substituated by phenil group and process for production of the active substance
FR2553100B1 (fr) Compositions renfermant des proteines de la membrane cellulaire de lymphocytes t, et procede de preparation de cette composition
EP0141374A3 (de) Herstellung von Kapseln unter Anwendung von biologisch aktiven Substraten
HUT52752A (en) Fungicides containing as active substance acyl-aminbenzamids and process for production of the active substances
HUT47570A (en) Insecticides containing as active substance 3-substituated-1-/chlor-tiasole-5-il-methil/-2-nitroamin-1,3-diaza-cycloalkans and process for production of the active substances
BE879173A (fr) Procede de preparation d'un allergene traite par un aldehyde, produit obtenu et son application therapeutique
HUT44900A (en) Insecticides containing as active substance aryl-piridone derivatives and process for production of the active substances and their intermediates
ATE244510T1 (de) Fruchterzeugnisse
JPS557014A (en) Antitumor agent and its preparation
CA2269077A1 (en) Keratinocyte growth factor-2 products
NO885467L (no) Soetningsmiddel, toerrprodukt inneholdende soetningsmiddeletog fremgangsmaate til fremstilling av middelet og produktet
HUT48797A (en) Insecticides, acarycides and nematocides containing as active substance derivatives of aryl-pirrol and process for production of the active substances
WO1990007260A3 (en) 2,3-methanoproline
IE45420L (en) Functional proteins.
DE2966043D1 (en) Process for the preparation of oside derivatives, derivatives so obtained and their biological applications
HUT53610A (en) Herbicides containing derivatives of 5-(3,4,5,6-tetrahydroftalamid)-cinnamon acid and process for production of the active substances
HU904125D0 (en) Herbicide preparatives containing substituted derivatives of benzoxazolinone and those of benzoxazinone as active substance and process for producing the active substances
HUT48801A (en) Acarycides and insecticides containing as active substance derivatives of benzoil-carbamide and process for production of the active substances
EP0354850A3 (de) Herstellung von immobilisierten Lipasen und deren Verwendung zur Synthese von Glyceriden
BE878110A (fr) Nouveaux derives du 1,4-bis-phenoxy-butane utilisables pour la lutte contre la vegetation indesirable et leur preparation
HU200896B (en) Fungicides containing as active substance derivatives of 2-[(o-substituated)-alkyl)]-2-tio-1,3,2-oxatiophospholane and process for production of the active substance

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 96199329.4

Country of ref document: CN

AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM

AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1996934811

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2235243

Country of ref document: CA

Ref document number: 2235243

Country of ref document: CA

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: PV1998-1179

Country of ref document: CZ

WWE Wipo information: entry into national phase

Ref document number: 320276

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 50998

Country of ref document: SK

WWE Wipo information: entry into national phase

Ref document number: 1998/00715

Country of ref document: TR

ENP Entry into the national phase

Ref document number: 1997 516286

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: PA/A/1998/003264

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 1019980703022

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 09051918

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 1996934811

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: PV1998-1179

Country of ref document: CZ

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1019980703022

Country of ref document: KR

WWG Wipo information: grant in national office

Ref document number: 1996934811

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: PV1998-1179

Country of ref document: CZ

WWR Wipo information: refused in national office

Ref document number: 1019980703022

Country of ref document: KR